source
- Democratic doctors celebrate gains as MAHA’s future remains uncertain after electionThe STAT+ D.C. Diagnosis newsletter reports that doctors aligned with the Democratic Party secured notable wins in recent political battles. At the same time, the Medicare for All (MAHA) initiativ…
- ProMis shares tumble after competitor's Alzheimer trial failure, CEO calls reaction overblownProMis Neurosciences, developer of an amyloid‑targeting Alzheimer’s therapy, saw its stock plunge sharply last week. The decline came after Acumen Pharmaceuticals announced that its own amyloid‑ta…